Type 2 diabetes mellitus (T2DM), characterized by insulin resistance and declining insulin secretion, affects an estimated 537 million adults worldwide, with a projected increase of approximately 20% by 2030. This evidence concerns the gene INS and type 2 diabetes mellitus.